What the company does
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. The company is headquartered in Novato, California.
What the weekly tape is saying
RARE closed the latest completed week at 24.35 USD. The 4-week return is -2.6% and the 12-week return is 22.5%. Trend Signal is inactive, Market Dynamics is 0.26. Setup signature: Risk-first tape with a 26/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 25.43 USD
- Vs Trend Line
- -4.2%
- Fair Value
- 38.32 USD
- Vs Fair Value
- -36.5%
- 52W High
- 42.37 USD
- 52W Low
- 18.29 USD
- Drawdown
- -42.5%
- Range Position
- 25.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 1
- 52W Active Breadth
- 1.9%
- Sector Scope
- US Healthcare
- Sector Rank
- 91 of 1038
- Sector Percentile
- 91.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- 63 of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.26
- 4W MD Change
- -48.0%
- Relative Strength
- -26.89
- 4W RS Change
- 4.2%
- Expectation
- Undecided
- Probability
- 51.91%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 7.9M
- 13W Average
- 8.7M
- 52W Average
- 9.7M
- Vs 13W
- 0.9x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.1%
- 52W Volatility
- 8.4%
- Upside Weeks
- 30
- Downside Weeks
- 22
- Downside Breadth
- 42.3%
- Avg Gain / Loss
- 4.8% / -7.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 2.3B
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 24.35 USD | 11.1% | 25.43 USD | 38.32 USD | 0.26 | -26.89 | 7.9M | Off |
| 5 Jun 2026 | 21.91 USD | -8.5% | 25.72 USD | 38.48 USD | 0.24 | -33.74 | 8.7M | Off |
| 29 May 2026 | 23.94 USD | 2.4% | 26.01 USD | 38.66 USD | 0.43 | -31.96 | 6.0M | Off |
| 22 May 2026 | 23.39 USD | -6.4% | 26.36 USD | 38.84 USD | 0.49 | -32.51 | 7.6M | Off |
| 15 May 2026 | 25.00 USD | -4.3% | 26.70 USD | 39.01 USD | 0.49 | -28.07 | 7.2M | Off |
| 8 May 2026 | 26.12 USD | 5.5% | 26.96 USD | 39.17 USD | 0.53 | -26.06 | 10.3M | Off |
| 1 May 2026 | 24.77 USD | 2.8% | 27.13 USD | 39.30 USD | 0.36 | -27.03 | 8.8M | Off |
| 24 Apr 2026 | 24.10 USD | -2.9% | 27.35 USD | 39.44 USD | 0.16 | -29.10 | 7.2M | Off |
| 17 Apr 2026 | 24.81 USD | 6.5% | 27.52 USD | 39.57 USD | -0.18 | -26.55 | 8.8M | Off |
| 10 Apr 2026 | 23.30 USD | 3.8% | 27.63 USD | 39.68 USD | -0.57 | -27.89 | 8.0M | Off |
| 2 Apr 2026 | 22.45 USD | 15.8% | 27.86 USD | 39.78 USD | -0.84 | -28.39 | 10.7M | Off |
| 27 Mar 2026 | 19.38 USD | -2.5% | 28.17 USD | 39.89 USD | -0.98 | -36.61 | 11.6M | Off |
| 20 Mar 2026 | 19.87 USD | -6.9% | 28.52 USD | 40.02 USD | -0.93 | -38.12 | 10.7M | Off |
| 13 Mar 2026 | 21.34 USD | 0.4% | 28.86 USD | 40.13 USD | -0.88 | -35.91 | 10.9M | Off |